ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Two Japanese chemical companies are increasing their presence in the active pharmaceutical ingredient (API) business. Sumitomo Chemical says it will build a third plant in Japan—this one in Oita City—for small-molecule APIs and intermediates. The firm says the project will enhance its leading position in Japan. Meanwhile, AGC says it will spend $100 million to expand its small-molecule API plant in Malgrat de Mar, Spain. AGC acquired the facility in 2019.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X